Our panel of experts bring years of experience and deep insights into the evolving landscape of safety and regulatory compliance. Gain first-hand knowledge and specialized perspectives on the latest trends:

In this webinar, we will present key insights from preliminary findings by the TUFTS Center for the Study of Drug Development, exploring how a comprehensive model that brings CDMO and CRO services under one roof can significantly impact the expected Net Present Value (eNPV) of drug development programs. We will demonstrate how streamlined services across drug substance, drug product, and clinical research can enhance efficiency, reduce timelines, and ultimately deliver high-quality therapies to patients faster. Key takeaways include:

Join us for expert insights into:

In this latest white paper, global leading CRO, Novotech, explores the latest advancements, trends and challenges in global RNA research. Access it now to gain insights and key statistics on:

Liver cancer is one of the leading causes of cancer death, with new cases predicted to rise by an alarming 70% by the time we reach 2025 (vs. 2022). Hepatocellular carcinoma, or HCC, accounts for 90% of cases, and poses significant challenges in treatment. Access this in-depth report to explore the global drug development landscape, and how promising advances in treatments are providing hope for the future. Explore topics including:

Gain a comprehensive understanding of both the scientific and practical considerations in peptide drug development for oral administration. Join us for a deep dive into:

Established originally from radiation therapy, radiopharmaceuticals have made significant development progress in recent years. In 2018, the FDA approved Lutathera for neuroendocrine tumors, signifying a new hope in the treatment of solid tumors. As the global clinical trial landscape continues to evolve, this white paper explores:

Don’t miss the key information in your free Insights brief. This Insights brief covers:

All new biologics begin at the bench with process development, but the ultimate goal is to bring the process to the production scale. Process development and bioprocess scale-up present many challenges, including maintaining consistent and reproducible growth kinetics, productivity, cell health, and mass transfer. This conversation will focus on strategies to meet these challenges for scaling from bench scale to pilot scale, including effective control strategies for process parameters such as agitation, dissolved 02 and CO2, and nutrient supplementation to ensure optimal cell performance and product yield. Join experts from Thermo Fisher Scientific as you will learn: